Tonix Pharmaceuticals Holding Corp (OTCBB - OTCQB:TNXPD)
| 6.50 Data as of May 16 |  0.00 / 0.00%Today’s Change | 2.25 Today|||52-Week Range 21.80 | -40.91% Year-to-Date |
Latest TNXPD News | Press Releases
No recent news for Tonix Pharmaceuticals Holding Corp.
Today’s Trading
| Previous close | 6.50 |
| Today’s open | n.a. |
| Day’s range | -- - -- |
| Volume | 0 |
| Average volume (3 months) | 1,064 |
| Market cap | -- |
| Dividend yield | -- |
Data as of 05/16/2013
Growth & Valuation
| Earnings growth (last year) | -75.00% |
| Earnings growth (this year) | -900.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVGNNovogen Ltd | -0.05 | -1.22% |
| TZYMTranzyme Inc | +0.01 | +1.92% |
| BTHEBoston Therapeutics ... | 0.00 | 0.00% |
| AXNAoxing Pharmaceutica... | +0.01 | +2.27% |
Data as of 3:59pm ET, 05/17/2013
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$9.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer Seth Lederman, MD |
Chief Financial Officer & Treasurer Leland J. Gershell, MD, PhD |
Corporate headquarters New York, New York |
Forecasts
